Pricing Log in Create free account

Nanobiotix S.A. - Sponsored ADR (NBTX) vs Precigen, Inc. (PGEN)

Nanobiotix S.A. - Sponsored ADR and Precigen, Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and Precigen, Inc. are of similar size ($1.5B and $1.5B). Nanobiotix S.A. - Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. has the higher net margin (15.6% vs 0.00%) and the higher return on invested capital (15.9% vs 0.00%). Across the 16 metrics below, Precigen, Inc. leads on 12 and Nanobiotix S.A. - Sponsored ADR on 4.

Valuation

Metric NBTX PGEN Biotechnology median
P/E n/m 60.27 10.60
P/S 6,111.93 10.11 9.40
P/B n/m 18.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 43.41 0.66
EV/Sales 5,356.43 10.51 9.02
Earnings yield (10.85%) 1.66% (32.88%)
Free cash flow yield (13.68%) (4.68%) (23.13%)

Profitability

Metric NBTX PGEN Biotechnology median
Gross margin 0.00% 91.42% 68.51%
Operating margin 0.00% 21.43% 0.00%
Net margin 0.00% 15.55% 0.00%
Free cash flow margin 0.00% (47.35%) 0.00%
Return on equity 0.00% 38.84% (51.96%)
Return on assets 0.00% 12.73% (46.06%)
Return on invested capital 0.00% 15.93% 0.00%

Growth

Metric NBTX PGEN Biotechnology median
Revenue growth (TTM) — 2,387.61% 6.76%
EPS growth (last fiscal year) 63.46% (191.49%) 29.88%
Revenue growth, 5-year CAGR 66.64% (21.26%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBTX PGEN Biotechnology median
Debt to equity 0.00 1.12 0.00
Current ratio 1.44 5.58 4.97
Net debt to EBITDA 5.66 0.04 1.01

Dividend

Metric NBTX PGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NBTX PGEN Biotechnology median
Market cap 1.53b 1.51b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack